Changing spectrum and mortality disparities of etiology of liver cirrhosis in Beijing, China

被引:2
作者
Li, Min [1 ,2 ,3 ]
Wei, Zaihua [4 ]
Su, Jianting [4 ]
Wu, Xiaoning [5 ,6 ]
Xie, Xueqin [7 ]
You, Hong [5 ,6 ]
Jia, Jidong [5 ,6 ]
Kong, Yuanyuan [1 ,2 ,3 ]
机构
[1] Capital Med Univ, Beijing Friendship Hosp, Clin Epidemiol & EBM Unit, Beijing, Peoples R China
[2] Beijing Clin Res Inst, Beijing, Peoples R China
[3] Natl Clin Res Ctr Digest Dis, Methodol Platform, Beijing, Peoples R China
[4] Beijing Ctr Dis Prevent & Control, Stat Ctr, Beijing, Peoples R China
[5] Capital Med Univ, Beijing Friendship Hosp, Liver Res Ctr, Beijing, Peoples R China
[6] Natl Clin Res Ctr Digest Dis, Beijing, Peoples R China
[7] Natl Hlth & Family Planning Commiss Peoples Republ, Stat Ctr, Beijing, Peoples R China
基金
中国国家自然科学基金;
关键词
cirrhosis; cirrhosis complication; etiology; hepatocellular carcinoma; liver-related death; CLINICAL-PRACTICE GUIDELINES; GLOBAL BURDEN; HEPATITIS-B; DISEASE;
D O I
10.1002/jmv.29405
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Liver cirrhosis remains a major health concern globally, but its epidemiology and etiology evolve with time. However, the changing pattern in etiology and cause of liver-related mortality for patients with cirrhosis are not fully elucidated. Herein, our aim was to characterize the temporal trend of the etiological spectrum and evaluate the impact of etiology on liver-related death among patients with compensated cirrhosis (CC) in Beijing, China. Clinical profiles of patients with CC discharged between January 2008 and December 2015 were retrieved from the Beijing hospital discharge database. The mortalities of different etiologies of cirrhosis were calculated. The risks of readmission and liver-related death associated with etiologies were evaluated by the Cox regression model. A total of 23 978 cirrhotic patients were included. The predominant cause was hepatitis B virus (HBV) (58.93%), followed by alcohol (21.35%), autoimmune (14.85%), miscellaneous etiologies (3.55%), and hepatitis C virus (HCV) (1.32%). From 2008 to 2015, the proportion of HBV-related cirrhosis decreased to 28.11%. Meanwhile, the proportions of autoimmune- and miscellaneous-related cirrhosis increased to 28.54% and 13.11%. The risk of liver-related death ranked the highest in patients with miscellaneous cirrhosis, followed by HBV-related cirrhosis, alcohol-related cirrhosis, autoimmune-related cirrhosis, and HCV-related cirrhosis. The 5-year rates of liver-related death were 22.56%, 18.99%, 18.77%, 16.01%, and 10.76%, respectively. HBV-related cirrhosis caused the highest risk of hepatocellular carcinoma (HCC)-related death, whereas alcohol- and miscellaneous-related cirrhosis caused higher risks of decompensation (DC)-related death than HBV-related cirrhosis, with hazard ratios of 1.35 (95% confidence interval [CI]: 1.24-1.48) and 1.20 (95% CI: 1.03-1.40), respectively. HBV remained a common cause of liver cirrhosis but gradually decreased. Mortality disparities existed in etiologies, with higher risks of HCC-related death in HBV-related cirrhosis, and DC-related death in alcohol- and miscellaneous-related cirrhosis.
引用
收藏
页数:9
相关论文
共 27 条
[1]   Worldwide prevalence of hepatitis B virus and hepatitis C virus among patients with cirrhosis at country, region, and global levels: a systematic review [J].
Alberts, Catharina J. ;
Clifford, Gary M. ;
Georges, Damien ;
Negro, Francesco ;
Lesi, Olufunmilayo A. ;
Hutin, Yvan J. -F ;
de Martel, Catherine .
LANCET GASTROENTEROLOGY & HEPATOLOGY, 2022, 7 (08) :724-735
[2]  
Chang PE, 2015, ANN ACAD MED SINGAP, V44, P218
[3]   Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level [J].
Chen, CJ ;
Yang, HI ;
Su, J ;
Jen, CL ;
You, SL ;
Lu, SN ;
Huang, GT ;
Iloeje, UH .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (01) :65-73
[4]   Estimating average annual per cent change in trend analysis [J].
Clegg, Limin X. ;
Hankey, Benjamin F. ;
Tiwari, Ram ;
Feuer, Eric J. ;
Edwards, Brenda K. .
STATISTICS IN MEDICINE, 2009, 28 (29) :3670-3682
[5]   Prevention of Chronic Hepatitis B after 3 Decades of Escalating Vaccination Policy, China [J].
Cui, Fuqiang ;
Shen, Lipin ;
Li, Li ;
Wang, Huaqing ;
Wang, Fuzhen ;
Bi, Shengli ;
Liu, Jianhua ;
Zhang, Guomin ;
Wang, Feng ;
Zheng, Hui ;
Sun, Xiaojin ;
Miao, Ning ;
Yin, Zundong ;
Feng, Zijian ;
Liang, Xiaofeng ;
Wang, Yu .
EMERGING INFECTIOUS DISEASES, 2017, 23 (05) :765-772
[6]   Transition in the etiology of liver cirrhosis in Japan: a nationwide survey [J].
Enomoto, Hirayuki ;
Ueno, Yoshiyuki ;
Hiasa, Yoichi ;
Nishikawa, Hiroki ;
Hige, Shuhei ;
Takikawa, Yasuhiro ;
Taniai, Makiko ;
Ishikawa, Toru ;
Yasui, Kohichiroh ;
Takaki, Akinobu ;
Takaguchi, Koichi ;
Ido, Akio ;
Kurosaki, Masayuki ;
Kanto, Tatsuya ;
Nishiguchi, Shuhei .
JOURNAL OF GASTROENTEROLOGY, 2020, 55 (03) :353-362
[7]   Evidence-based clinical practice guidelines for liver cirrhosis 2015 [J].
Fukui, Hiroshi ;
Saito, Hidetsugu ;
Ueno, Yoshiyuki ;
Uto, Hirofumi ;
Obara, Katsutoshi ;
Sakaida, Isao ;
Shibuya, Akitaka ;
Seike, Masataka ;
Nagoshi, Sumiko ;
Segawa, Makoto ;
Tsubouchi, Hirohito ;
Moriwaki, Hisataka ;
Kato, Akinobu ;
Hashimoto, Etsuko ;
Michitaka, Kojiro ;
Murawaki, Toshikazu ;
Sugano, Kentaro ;
Watanabe, Mamoru ;
Shimosegawa, Tooru .
JOURNAL OF GASTROENTEROLOGY, 2016, 51 (07) :629-650
[8]   Etiologies and outcomes of cirrhosis in a large contemporary cohort [J].
Hagstrom, Hannes ;
Lindfors, Andrea ;
Holmer, Magnus ;
Bengtsson, Bonnie ;
Bjorkstrom, Karl ;
Hegmar, Hannes ;
von Seth, Erik .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2021, 56 (06) :727-732
[9]   AASLD guidelines for the treatment of hepatocellular carcinoma [J].
Heimbach, Julie K. ;
Kulik, Laura M. ;
Finn, Richard S. ;
Sirlin, Claude B. ;
Abecassis, Michael M. ;
Roberts, Lewis R. ;
Zhu, Andrew X. ;
Murad, M. Hassan ;
Marrero, Jorge A. .
HEPATOLOGY, 2018, 67 (01) :358-380
[10]   Global epidemiology of cirrhosis - aetiology, trends and predictions [J].
Huang, Daniel Q. ;
Terrault, Norah A. ;
Tacke, Frank ;
Gluud, Lise Lotte ;
Arrese, Marco ;
Bugianesi, Elisabetta ;
Loomba, Rohit .
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2023, 20 (06) :388-398